phase 3
iiiii 2
randomized 2
study 3
compare 2
efficacy 2
safety 2
rigosertib 2
plus 2
gemcitabine 4
versus 2
alone 2
patients 2
previously 2
untreated 2
metastatic 2
pancreatic 2
cancer 3
mk 1
allosteric 1
inhibitor 1
akt 1
secondline 1
therapy 1
advanced 1
gastric 1
gastroesophageal 1
junction 1
swog 1
cooperative 1
group 1
trial 1
s 1
